These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26508726)

  • 1. Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device.
    Morris AA; Pekarek A; Wittersheim K; Cole RT; Gupta D; Nguyen D; Laskar SR; Butler J; Smith A; Vega JD
    J Heart Lung Transplant; 2015 Dec; 34(12):1570-7. PubMed ID: 26508726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices.
    Chiang YP; Cox D; Schroder JN; Daneshmand MA; Blue LJ; Patel CB; DeVore AD; Bishawi M; Milano CA
    J Card Surg; 2020 Feb; 35(2):383-389. PubMed ID: 31808964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and Readmissions After Continuous Flow Left Ventricular Assist Device: Heartmate II Versus Heartware Ventricular Assist Device.
    Tuncer ON; Kemaloğlu C; Erbasan O; Gölbaşı I; Türkay C; Bayezid Ö
    Transplant Proc; 2016; 48(6):2157-61. PubMed ID: 27569963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum of complications following left ventricular assist device placement.
    Yuan N; Arnaoutakis GJ; George TJ; Allen JG; Ju DG; Schaffer JM; Russell SD; Shah AS; Conte JV
    J Card Surg; 2012 Sep; 27(5):630-8. PubMed ID: 22978843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke.
    Nassif ME; Tibrewala A; Raymer DS; Andruska A; Novak E; Vader JM; Itoh A; Silvestry SC; Ewald GA; LaRue SJ
    J Heart Lung Transplant; 2015 Apr; 34(4):503-8. PubMed ID: 25540881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.
    Cho SM; Moazami N; Frontera JA
    Neurocrit Care; 2017 Aug; 27(1):17-25. PubMed ID: 28324260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular dimension decrement index early after axial flow assist device implantation: A novel risk marker for late pump thrombosis.
    Joyce E; Stewart GC; Hickey M; Coakley L; Rivero JM; Gosev I; Givertz MM; Couper GS; Mehra MR
    J Heart Lung Transplant; 2015 Dec; 34(12):1561-9. PubMed ID: 26508725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis.
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; García Sáez D; Amrani M; Bahrami T; De Robertis F; Wahlers T; Banner NR; Popov AF; Simon AR
    Artif Organs; 2015 Mar; 39(3):212-9. PubMed ID: 25175547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Sparrow CT; Nassif ME; Raymer DS; Novak E; LaRue SJ; Schilling JD
    JACC Heart Fail; 2015 Dec; 3(12):956-64. PubMed ID: 26577618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender Differences in Outcomes After Implantation of Left Ventricular Assist Devices.
    Ahmed A; Adegbala O; Akintoye E; Inampudi C; Ajam M; Yassin AS; Olawusi E; Shokr M; Alvarez P; Briasoulis A
    Ann Thorac Surg; 2020 Mar; 109(3):780-786. PubMed ID: 31479642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke After Left Ventricular Assist Device Implantation: Outcomes in the Continuous-Flow Era.
    Harvey L; Holley C; Roy SS; Eckman P; Cogswell R; Liao K; John R
    Ann Thorac Surg; 2015 Aug; 100(2):535-41. PubMed ID: 26070599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
    Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
    Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.
    Ochiai Y; McCarthy PM; Smedira NG; Banbury MK; Navia JL; Feng J; Hsu AP; Yeager ML; Buda T; Hoercher KJ; Howard MW; Takagaki M; Doi K; Fukamachi K
    Circulation; 2002 Sep; 106(12 Suppl 1):I198-202. PubMed ID: 12354733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical approach to continuous-flow left ventricular assist device explantation: A comparison of outcomes.
    Baldwin AC; Sandoval E; Letsou GV; Mallidi HR; Cohn WE; Frazier OH
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):192-8. PubMed ID: 26344685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.